Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Colorectal Neoplasms 2Hepatitis 1Esophageal Neoplasms 1Colonic Neoplasms 1Chemical and Drug Induced Liver Injury 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

Bevacizumab 233Fluorouracil 219Oxaliplatin 215Irinotecan 215Leucovorin 198Capecitabine 153Cetuximab 145Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15apatinib 14Gemcitabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × Ursodeoxycholic Acid × Clear all
NCT01149304 2017-11-20

ELDORADO

University of Magdeburg

Phase 2 Completed
22 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00062023 2012-07-30

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
12 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡